Superparamagnetic iron oxide: pharmacokinetics and toxicity

Department of Radiology, Massachusetts General Hospital, Boston.

The pharmacokinetics (distribution, metabolism, bioavailability, excretion) and toxicity (acute and subacute toxicity, mutagenicity) of a superparamagnetic iron oxide preparation (AMI-25), currently used in clinical trials, were evaluated by 59Fe radiotracer studies, measurements of relaxation times, the ability to reverse iron deficiency anemia, histologic examination, and laboratory parameters. One hour after administration of AMI-25 to rats (18 mumol Fe/kg; 1 mg Fe/kg), 82.6 +/- 0.3% of the administered dose was sequestered in the liver and 6.2 +/- 7.6% in the spleen. Peak concentrations of 59Fe were found in liver after 2 hr and in the spleen after 4 hr. 59Fe slowly cleared from liver (half-life, 3 days) and spleen (half-life, 4 days) and was incorporated into hemoglobin of erythrocytes in a time-dependent fashion. The half-time of the T2 effect on liver and spleen (24-48 hr) was shorter than the 59Fe clearance, indicating metabolism of AMI-25 into other forms of iron. IV administration of AMI-25 (30 mg Fe/kg) corrected iron-deficiency anemia and showed bioavailability similar to that of commercially available IV iron preparations within 7 days. No acute or subacute toxic effects were detected by histologic or serologic studies in rats or beagle dogs who received a total of 3000 mumol Fe/kg, 150 times the dose proposed for MR imaging of the liver. Our results indicate that AMI-25 is a fully biocompatible potential contrast agent for MR.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Bierry, F. Jehl, N. Boehm, P. Robert, G. Prevost, J.-L. Dietemann, H. Desal, and S. Kremer Macrophage Activity in Infected Areas of an Experimental Vertebral Osteomyelitis Model: USPIO-enhanced MR Imaging--Feasibility Study Radiology, July 1, 2008; 248(1): 114 - 123. [Abstract] [Full Text] [PDF]

				S. Y. Shaw, E. C. Westly, M. J. Pittet, A. Subramanian, S. L. Schreiber, and R. Weissleder Perturbational profiling of nanomaterial biologic activity PNAS, May 27, 2008; 105(21): 7387 - 7392. [Abstract] [Full Text] [PDF]

				B. Polyak, I. Fishbein, M. Chorny, I. Alferiev, D. Williams, B. Yellen, G. Friedman, and R. J. Levy High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents PNAS, January 15, 2008; 105(2): 698 - 703. [Abstract] [Full Text] [PDF]

				S. N. Ebert, D. G. Taylor, H.-L. Nguyen, D. P. Kodack, R. J. Beyers, Y. Xu, Z. Yang, and B. A. French Noninvasive Tracking of Cardiac Embryonic Stem Cells In Vivo Using Magnetic Resonance Imaging Techniques Stem Cells, November 1, 2007; 25(11): 2936 - 2944. [Abstract] [Full Text] [PDF]

				R. D. Oude Engberink, S. M. A. van der Pol, E. A. Dopp, H. E. de Vries, and E. L. A. Blezer Comparison of SPIO and USPIO for in Vitro Labeling of Human Monocytes: MR Detection and Cell Function Radiology, May 1, 2007; 243(2): 467 - 474. [Abstract] [Full Text] [PDF]

				S. Wisel, S. M. Chacko, M. L. Kuppusamy, R. P. Pandian, M. Khan, V. K. Kutala, R. W. Burry, B. Sun, P. Kwiatkowski, and P. Kuppusamy Labeling of skeletal myoblasts with a novel oxygen-sensing spin probe for noninvasive monitoring of in situ oxygenation and cell therapy in heart Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1254 - H1261. [Abstract] [Full Text] [PDF]

				D. Simberg, T. Duza, J. H. Park, M. Essler, J. Pilch, L. Zhang, A. M. Derfus, M. Yang, R. M. Hoffman, S. Bhatia, et al. Biomimetic amplification of nanoparticle homing to tumors PNAS, January 16, 2007; 104(3): 932 - 936. [Abstract] [Full Text] [PDF]

				S. N. Gandhi, M. A. Brown, J. G. Wong, D. A. Aguirre, and C. B. Sirlin MR Contrast Agents for Liver Imaging: What, When, How RadioGraphics, November 1, 2006; 26(6): 1621 - 1636. [Abstract] [Full Text] [PDF]

				N. V. Evgenov, Z. Medarova, J. Pratt, P. Pantazopoulos, S. Leyting, S. Bonner-Weir, and A. Moore In Vivo Imaging of Immune Rejection in Transplanted Pancreatic Islets Diabetes, September 1, 2006; 55(9): 2419 - 2428. [Abstract] [Full Text] [PDF]

				A. M. Lutz, J. K. Willmann, K. Goepfert, B. Marincek, and D. Weishaupt Hepatocellular Carcinoma in Cirrhosis: Enhancement Patterns at Dynamic Gadolinium- and Superparamagnetic Iron Oxide-enhanced T1-weighted MR Imaging Radiology, November 1, 2005; 237(2): 520 - 528. [Abstract] [Full Text] [PDF]

				G. T. Yocum, L. B. Wilson, P. Ashari, E. K. Jordan, J. A. Frank, and A. S. Arbab Effect of Human Stem Cells Labeled with Ferumoxides- Poly-L-lysine on Hematologic and Biochemical Measurements in Rats Radiology, May 1, 2005; 235(2): 547 - 552. [Abstract] [Full Text] [PDF]

				S. H. Kim, D. Choi, S. H. Kim, J. H. Lim, W. J. Lee, M. J. Kim, H. K. Lim, and S. J. Lee Ferucarbotran-Enhanced MRI Versus Triple-Phase MDCT for the Preoperative Detection of Hepatocellular Carcinoma Am. J. Roentgenol., April 1, 2005; 184(4): 1069 - 1076. [Abstract] [Full Text] [PDF]

				A. M. Lutz, C. Seemayer, C. Corot, R. E. Gay, K. Goepfert, B. A. Michel, B. Marincek, S. Gay, and D. Weishaupt Detection of Synovial Macrophages in an Experimental Rabbit Model of Antigen-induced Arthritis: Ultrasmall Superparamagnetic Iron Oxide-enhanced MR Imaging Radiology, October 1, 2004; 233(1): 149 - 157. [Abstract] [Full Text] [PDF]

				A. S. Arbab, G. T. Yocum, H. Kalish, E. K. Jordan, S. A. Anderson, A. Y. Khakoo, E. J. Read, and J. A. Frank Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI Blood, August 15, 2004; 104(4): 1217 - 1223. [Abstract] [Full Text] [PDF]

				M. F. Kircher, U. Mahmood, R. S. King, R. Weissleder, and L. Josephson A Multimodal Nanoparticle for Preoperative Magnetic Resonance Imaging and Intraoperative Optical Brain Tumor Delineation Cancer Res., December 1, 2003; 63(23): 8122 - 8125. [Abstract] [Full Text] [PDF]

				E. C. Unger How Can Superparamagnetic Iron Oxides Be Used to Monitor Disease and Treatment? Radiology, December 1, 2003; 229(3): 615 - 616. [Full Text] [PDF]

				A. S. Arbab, L. A. Bashaw, B. R. Miller, E. K. Jordan, B. K. Lewis, H. Kalish, and J. A. Frank Characterization of Biophysical and Metabolic Properties of Cells Labeled with Superparamagnetic Iron Oxide Nanoparticles and Transfection Agent for Cellular MR Imaging Radiology, December 1, 2003; 229(3): 838 - 846. [Abstract] [Full Text] [PDF]

				S. Kumano, T. Murakami, T. Kim, M. Hori, A. Okada, T. Sugiura, Y. Noguchi, S. Kawata, K. Tomoda, and H. Nakamura Using Superparamagnetic Iron Oxide-Enhanced MRI to Differentiate Metastatic Hepatic Tumors and Nonsolid Benign Lesions Am. J. Roentgenol., November 1, 2003; 181(5): 1335 - 1339. [Abstract] [Full Text] [PDF]

				H. E. Daldrup-Link, M. Rudelius, R. A. J. Oostendorp, M. Settles, G. Piontek, S. Metz, H. Rosenbrock, U. Keller, U. Heinzmann, E. J. Rummeny, et al. Targeting of Hematopoietic Progenitor Cells with MR Contrast Agents Radiology, September 1, 2003; 228(3): 760 - 767. [Abstract] [Full Text] [PDF]

				M.-J. Kim, J. H. Kim, J.-J. Chung, M. S. Park, J. S. Lim, and Y. T. Oh Focal Hepatic Lesions: Detection and Characterization with Combination Gadolinium- and Superparamagnetic Iron Oxide-enhanced MR Imaging Radiology, September 1, 2003; 228(3): 719 - 726. [Abstract] [Full Text] [PDF]

				A. Ba-Ssalamah, W. Schima, M. T. Schmook, K. F. Linnau, N. Schibany, T. Helbich, P. Reimer, F. Laengle, F. Wrba, A. Kurtaran, et al. Atypical Focal Nodular Hyperplasia of the Liver: Imaging Features of Nonspecific and Liver-Specific MR Contrast Agents Am. J. Roentgenol., December 1, 2002; 179(6): 1447 - 1456. [Abstract] [Full Text] [PDF]

				C. U. Herborn, T. C. Lauenstein, F. M. Vogt, R. B. Lauffer, J. F. Debatin, and S. G. Ruehm Interstitial MR Lymphography with MS-325: Characterization of Normal and Tumor-Invaded Lymph Nodes in a Rabbit Model Am. J. Roentgenol., December 1, 2002; 179(6): 1567 - 1572. [Abstract] [Full Text] [PDF]

				S. K. Kim, S. H. Kim, W. J. Lee, H. Kim, J. W. Seo, D. Choi, H. K. Lim, S. J. Lee, and J. H. Lim Preoperative Detection of Hepatocellular Carcinoma: Ferumoxides-Enhanced Versus Mangafodipir Trisodium--Enhanced MR Imaging Am. J. Roentgenol., September 1, 2002; 179(3): 741 - 750. [Abstract] [Full Text] [PDF]

				H. Kobayashi, T. Saga, S. Kawamoto, N. Sato, A. Hiraga, T. Ishimori, J. Konishi, K. Togashi, and M. W. Brechbiel Dynamic Micro-Magnetic Resonance Imaging of Liver Micrometastasis in Mice with a Novel Liver Macromolecular Magnetic Resonance Contrast Agent DAB-Am64-(1B4M-Gd)64 Cancer Res., July 1, 2001; 61(13): 4966 - 4970. [Abstract] [Full Text] [PDF]

				S. G. Ruehm, C. Corot, P. Vogt, S. Kolb, and J. F. Debatin Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits Circulation, January 23, 2001; 103(3): 415 - 422. [Abstract] [Full Text] [PDF]

				M. Knauth, T. Egelhof, S. U. Roth, C. R. Wirtz, and K. Sartor Monocrystalline Iron Oxide Nanoparticles: Possible Solution to the Problem of Surgically Induced Intracranial Contrast Enhancement in Intraoperative MR Imaging AJNR Am. J. Neuroradiol., January 1, 2001; 22(1): 99 - 102. [Abstract] [Full Text] [PDF]

				O. Hauger, C. Delalande, C. Deminière, B. Fouqueray, C. Ohayon, S. Garcia, H. Trillaud, C. Combe, and N. Grenier Nephrotoxic Nephritis and Obstructive Nephropathy: Evaluation with MR Imaging Enhanced with Ultrasmall Superparamagnetic Iron Oxide-Preliminary Findings in a Rat Model Radiology, December 1, 2000; 217(3): 819 - 826. [Abstract] [Full Text]

				M. R. Paley, P. J. Mergo, G. M. Torres, and P. R. Ros Characterization of Focal Hepatic Lesions with Ferumoxides-Enhanced T2-Weighted MR Imaging Am. J. Roentgenol., July 1, 2000; 175(1): 159 - 163. [Abstract] [Full Text] [PDF]

				J. Ward, K. S. Naik, J. A. Guthrie, D. Wilson, and P. J. Robinson Hepatic Lesion Detection: Comparison of MR Imaging after the Administration of Superparamagnetic Iron Oxide with Dual-Phase CT by Using Alternative–Free Response Receiver Operating Characteristic Analysis Radiology, February 1, 1999; 210(2): 459 - 466. [Abstract] [Full Text]

				M. Taupitz, J. Schnorr, S. Wagner, C. Abramjuk, H. Pilgrimm, D. Kivelitz, T. Schink, J. Hansel, G. Laub, H. Hunigen, et al. Coronary MR Angiography: Experimental Results with a Monomer-stabilized Blood Pool Contrast Medium Radiology, January 1, 2002; 222(1): 120 - 126. [Abstract] [Full Text] [PDF]

				T. Allkemper, C. Bremer, L. Matuszewski, W. Ebert, and P. Reimer Contrast-enhanced Blood-Pool MR Angiography with Optimized Iron Oxides: Effect of Size and Dose on Vascular Contrast Enhancement in Rabbits Radiology, May 1, 2002; 223(2): 432 - 438. [Abstract] [Full Text] [PDF]